Clough Capital Partners’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-95,501
Closed -$10.1M 104
2025
Q4
$10.1M Hold
95,501
0.9% 36
2025
Q3
$12.1M Sell
95,501
-6,280
-6% -$748K 1.06% 35
2025
Q2
$12.5M Sell
101,781
-6,313
-6% -$721K 1.24% 31
2025
Q1
$10.9M Sell
108,094
-40
-0% -$3.9K 1.37% 29
2024
Q4
$9.99M Hold
108,134
1.13% 39
2024
Q3
$10.5M Sell
108,134
-27,515
-20% -$2.47M 1.07% 33
2024
Q2
$11.6M Sell
135,649
-23,555
-15% -$1.98M 1.27% 28
2024
Q1
$13.1M Sell
159,204
-4,735
-3% -$347K 1.45% 24
2023
Q4
$10.9M Buy
163,939
+26,200
+19% +$1.7M 1.21% 26
2023
Q3
$9.25M Buy
137,739
+800
+0.6% +$55K 0.99% 33
2023
Q2
$9.27M Buy
136,939
+50,839
+59% +$3.19M 0.93% 36
2023
Q1
$4.66M Buy
+86,100
New +$5.01M 0.5% 71

Other funds holding EHC

Clough Capital Partners's EHC Position: Q1 2026 in Review

Clough Capital Partners sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 95,501 shares — an estimated $10.1M sold.

Clough Capital Partners first reported a position in EHC in Q1 2023 and held it in 12 quarters. The position peaked at $13.1M in Q1 2024. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Clough Capital Partners reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Clough Capital Partners sold 95,501 Encompass Health shares in Q1 2026, an estimated $10.1M.
  • Clough Capital Partners first reported a position in Encompass Health in Q1 2023 and held it in 12 quarters.
  • Clough Capital Partners's Encompass Health position peaked at $13.1M in Q1 2024.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Clough Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.